<?xml version="1.0" encoding="UTF-8"?>
<p>To date, a review article summarizing the preclinical evidence of 
 <italic>C. longa</italic> or its active constituents, besides curcumin, against hepatobiliary diseases has not been published. Herein, we aimed to demonstrate available experimental results and the molecular mechanism of 
 <italic>C. longa</italic> and its four constituents that are related to the prevention and treatment of hepatobiliary diseases.
</p>
